当前位置:首页 - 行情中心 - 锦好医疗(920925) - 财务分析 - 现金流量表

锦好医疗

(920925)

  

流通市值:8.22亿  总市值:14.66亿
流通股本:5529.51万   总股本:9866.06万

现金流量表

报告期2026-03-312025-12-312025-09-302025-06-30
公司类型通用通用通用通用
一、经营活动产生的现金流量:
  销售商品、提供劳务收到的现金49,181,180.97265,964,142.73183,327,205.63117,991,684.81
  收到的税费返还4,942,058.9113,603,076.8412,632,243.199,049,295.56
  收到其他与经营活动有关的现金975,275.066,698,340.75,415,554.283,616,504.49
  经营活动现金流入小计55,098,514.94286,265,560.27201,375,003.1130,657,484.86
  购买商品、接受劳务支付的现金36,973,973.05162,620,467.09108,723,886.476,488,215.87
  支付给职工以及为职工支付的现金18,420,112.0466,477,526.850,984,126.0333,465,862.88
  支付的各项税费2,216,877.624,393,626.222,738,864.941,749,504.53
  支付其他与经营活动有关的现金7,779,291.1436,422,473.5123,527,876.8311,803,405.51
  经营活动现金流出小计65,390,253.85269,914,093.62185,974,754.2123,506,988.79
  经营活动产生的现金流量净额-10,291,738.9116,351,466.6515,400,248.97,150,496.07
二、投资活动产生的现金流量:
  收回投资收到的现金30,200,000148,000,000123,070,00057,185,000
  取得投资收益收到的现金82,387.95502,658.89337,973.98250,830.14
  处置固定资产、无形资产和其他长期资产收回的现金净额91037,988,069.31--
  收到的其他与投资活动有关的现金--7,600,000-
  投资活动现金流入小计30,283,297.95186,490,728.2131,007,973.9857,435,830.14
  购建固定资产、无形资产和其他长期资产支付的现金432,374.8414,388,386.499,201,065.754,653,631.4
  投资支付的现金27,000,000164,064,400149,826,45030,250,000
  支付其他与投资活动有关的现金-817,500--
  投资活动现金流出小计27,432,374.84179,270,286.49159,027,515.7534,903,631.4
  投资活动产生的现金流量净额2,850,923.117,220,441.71-28,019,541.7722,532,198.74
三、筹资活动产生的现金流量:
  吸收投资收到的现金1,754,00010,962,50010,962,500-
  取得借款收到的现金10,000,000---
  筹资活动现金流入平衡项目000-
  筹资活动现金流入小计11,754,00010,962,50010,962,500-
  偿还债务支付的现金-30,021,944.44--
  分配股利、利润或偿付利息支付的现金-3,575,472.33,564,697.06399,388.85
  支付其他与筹资活动有关的现金479,376.854,190,779.554,488,281.321,340,787.19
  筹资活动现金流出小计479,376.8537,788,196.298,052,978.381,740,176.04
  筹资活动产生的现金流量净额11,274,623.15-26,825,696.292,909,521.62-1,740,176.04
四、汇率变动对现金及现金等价物的影响-804,412.51-178,463.52533,734.92335,543.28
五、现金及现金等价物净增加额3,029,394.84-3,432,251.45-9,176,036.3328,278,062.05
  加:期初现金及现金等价物余额54,734,959.5658,167,211.0156,609,566.9756,658,632.44
  期末现金及现金等价物余额57,764,354.454,734,959.5647,433,530.6484,936,694.49
补充资料:
  净利润-14,787,500.67-7,263,462.96
  资产减值准备-5,255,550.04-564,782.83
  固定资产和投资性房地产折旧-9,972,402.58-4,692,916.43
  其中:固定资产折旧、油气资产折耗、生产性生物资产折旧-9,972,402.58-4,692,916.43
  无形资产摊销-479,710.58-236,994.89
  长期待摊费用摊销-856,417.41-451,280.65
  处置固定资产、无形资产和其他长期资产的损失-628,717.12--
  固定资产报废损失---648.91
  公允价值变动损失--10,218.63--11,506.85
  财务费用-253,091.52-521,963.13
  投资损失--432,428.15--3,882.03
  递延所得税--1,199,440.97--373,516.69
  其中:递延所得税资产减少--580,922.45-6,390.88
    递延所得税负债增加--618,518.52--379,907.57
  存货的减少-15,413,455.68-419,324.83
  经营性应收项目的减少--21,211,944.93-5,451,236.53
  经营性应付项目的增加--15,713,858.85--12,850,798.69
  其他-3,191,783.4--
  现金的期末余额-54,734,959.56-84,936,694.49
  减:现金的期初余额-58,167,211.01-56,658,632.44
  现金及现金等价物的净增加额--3,432,251.45-28,278,062.05
公告日期2026-04-292026-04-212025-10-292025-08-27
审计意见(境内)标准无保留意见
TOP↑